Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.
Ioannou GN, Berry K, Rajeevan N, Li Y, Yan L, Huang Y, Lin HM, Bui D, Hynes DM, Rowneki M, Bohnert A, Boyko EJ, Iwashyna TJ, Maciejewski ML, Smith VA, Berkowitz TSZ, O'Hare AM, Viglianti EM, Aslan M, Bajema KL.
Ioannou GN, et al. Among authors: lin hm.
Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-01015. Online ahead of print.
Ann Intern Med. 2025.
PMID: 39903865